Literature DB >> 29983344

Enzalutamide and metastasis risk in prostate cancer.

Elizabeth Gourd.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29983344     DOI: 10.1016/S1470-2045(18)30502-3

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  1 in total

1.  CDC20 and PTTG1 are Important Biomarkers and Potential Therapeutic Targets for Metastatic Prostate Cancer.

Authors:  Liang Dai; Zi-Xuan Song; Da-Peng Wei; Ji-Dong Zhang; Jun-Qiang Liang; Bai-Bing Wang; Wang-Teng Ma; Li-Ying Li; Yin-Lu Dang; Liang Zhao; Li-Min Zhang; Yu-Ming Zhao
Journal:  Adv Ther       Date:  2021-04-21       Impact factor: 3.845

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.